關於「Geodon IV」標籤，搜尋引擎有相關的訊息討論：

Intravenous Ziprasidone for Treatment of Delirium in the Intensive ...。

Intravenous Ziprasidone for Treatment of Delirium in the Intensive Care Unit ... Fraser GL Cox PM: Continuous infusion of haloperidol controls agitation in ...： tw | tw。

Geodon (Ziprasidone): Uses, Dosage, Side Effects, Interactions ...。

Geodon (Ziprasidone) may treat, side effects, dosage, drug interactions, warnings, ... trial in patients who met DSM-IV criteria for bipolar I disorder.： 。

圖片全部顯示。

Don't Push - AHRQ PSNet。

The psychiatry team recommended haloperidol administered via intravenous (IV) ... Intramuscular ziprasidone produced greater improvement in agitation and ...。

Haloperidol and Ziprasidone for Treatment of Delirium in Critical ...。

2018年12月27日 · In this double-blind, randomized, placebo-controlled trial of intravenous antipsychotic medications for the treatment of delirium in the ICU, ...： tw | tw。

Geodon Injection - FDA prescribing information, side effects and uses。

2021年7月1日 · Intravenous access should be established, and gastric lavage (after intubation, if patient is unconscious) and administration of activated ...： 。

Inadvertent administration of intravenous ziprasidone leading to ...。

Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation. Ann Pharmacother. 2008 Jun;42(6):902-3. doi: ...： 。

A 6 Week Randomized Double-Blind Placebo-Controlled Trial of ...。

2012年4月24日 · Objective To examine the efficacy of ziprasidone vs. placebo for the ... They did not meet DSM-IV criteria for a mixed or manic episode.。

Evaluation of intramuscular olanzapine and ziprasidone in the ...。

2021年1月8日 · agitation, intramuscular, olanzapine, ziprasidone, medically ill ... (QTc) prolongation with IV use.1 The previously published 2013 Society ...。

Long-Term Changes in Weight and Plasma Lipids during ... - Nature。

2007年7月18日 · The maximum length of exposure to ziprasidone was 58 weeks. ... disorder based on psychiatrist diagnostic evaluation using DSM-IV criteria.